⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5297786 | 0.72 | — | — | |
| SCHEMBL25352284 | 0.71 | — | — | |
| SCHEMBL1667413 | 0.71 | — | — | |
| SCHEMBL27550891 | 0.67 | — | — | |
| SCHEMBL2227258 | 0.67 | — | — | |
| SCHEMBL2955235 | 0.67 | — | — | |
| SCHEMBL29110050 | 0.67 | — | — | |
| SCHEMBL7325933 | 0.66 | — | — | |
| SCHEMBL30927993 | 0.64 | — | — | |
| SCHEMBL1303902 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3762383-B1 | POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF | US HEALTH (US) | 2023-12-06 | — | — | EP | disclosed |
| CN-117088865-A | 3CLpro protease inhibitor related substance and preparation method thereof | 齐鲁制药有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20210040074-A1 | POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF | THE UNITED STATES OF AMERICA,AS REPRESENTED BY THE SECRETARY,DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2021-02-11 | — | — | US | disclosed |
| EP-3762383-A1 | POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2021-01-13 | — | — | EP | disclosed |
| US-10435398-B2 | Oxazole orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2019-10-08 | — | — | US | disclosed |
| WO-2019173437-A1 | POSITIVE ALLOSTERIC MODULATORS OF DOPAMINE 1 RECEPTOR AND METHOD OF USE THEREOF | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-09-12 | — | — | WO | disclosed |
| US-10150751-B2 | Pyrrolidine orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2018-12-11 | — | — | US | disclosed |
| US-10011595-B2 | Ethyldiamine orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2018-07-03 | — | — | US | disclosed |
| US-9938276-B2 | 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2018-04-10 | — | — | US | disclosed |
| US-9920038-B2 | Methyl oxazole orexin receptor antagonists | MERCK SHARP & DOHME CORP. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20090099181-A1 | SULFOXIMINES AS KINASE INHIBITORS | ALLERGAN, INC. | 2009-04-16 | — | — | US | disclosed |
| WO-2008061236-A2 | SULFOXIMINES AS KINASE INHIBITORS | ALLERGAN, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-0399818-B1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC (CA) | 1995-08-16 | — | — | EP | disclosed |
| US-5166349-A | CHIRAL ORGANOIRON COMPLEXES AND USE FOR ASSYMETRIC REDUCTION | THE BRITISH PETROLEUM COMPANY, P.L.C. (GB) | 1992-11-24 | — | — | US | disclosed |
| EP-0255075-B1 | 2-(ACYLTHIO)METHYL DIHYDROPYRIDINES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991006550-A1 | CHIRAL ORGANOMETALLIC COMPLEXES AND USES THEREOF | THE BRITISH PETROLEUM COMPANY PLC (GB) | 1991-05-16 | — | — | WO | disclosed |
| EP-0426474-A1 | Chiral organometallic complexes and uses thereof | The British Petroleum Company p.l.c. (GB) | 1991-05-08 | — | — | EP | disclosed |
| EP-0399818-A1 | Diarylstyrylquinoline diacids | MERCK FROSST CANADA INC. (CA) | 1990-11-28 | — | — | EP | disclosed |
| US-4935433-A | 2-(acylthio)methyl dihydropyridines, and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) | 1990-06-19 | — | — | US | disclosed |
| EP-0255075-A1 | 2-(acylthio)methyl dihydropyridines, a process for their preparation and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1988-02-03 | — | — | EP | disclosed |